Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Genotropin delivery device now available for long-term replacement therapy in GHD

Jan. 24, 2000

Lipitor recommended for approval in Japan

Jan. 21, 2000

Ramipril and aminoguanidine both prevent albuminuria and normalize PKC in diabetic rats

Jan. 21, 2000

Schering's new agents for eating disorders and diabetes presented in international patent

Jan. 21, 2000

CardioRex phase II trials scheduled to begin this quarter

Jan. 20, 2000

Antiobesity agents from Novartis target the NPY Y5 receptor

Jan. 20, 2000

Lipid-lowering compounds designed at HMR (Aventis)

Jan. 20, 2000

Merck KGaA designs nontoxic hypoglycemic agents particularly useful for NIDDM

Jan. 19, 2000

Vivus and AstraZeneca resolve Muse distribution agreement

Jan. 18, 2000

Four-year results from Early Postmenopausal Intervention Cohort Study presented

Jan. 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...